findmyKOL

Yogita Rochlani, MBBS

Basic profile

Montefiore Health System

ORCIDNPI
RegionBronx, NY · NortheastSpecialtyAdvanced Heart Failure and Transplant CardiologyFocusCardiology
ActivityNot yet indexedfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Yogita Rochlani is a Cardiology physician affiliated with Montefiore Health System. OpenAlex indexes 99 publications with 2,247 citations (h-index 16).

Overview

Scholarship

indexed output and impact (OpenAlex)
99publications

Distinct works indexed by OpenAlex, matched via ORCID.

2,247citations

Total citations across indexed works.

16h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    82.2%
    Beta blocker18.7%
    Metoprolol Succinate81%Carvedilol19%
    Part D43 patients
    Angiotensin receptor-neprilysin inhibitor (ARNI)11.8%
    Entresto100%
    Part D34 patients

    + 9 more classes in this area

  • Metabolism & gastrointestinal

    10.4%
    SGLT2 inhibitor8.3%
    Jardiance51%Farxiga49%
    Part D19 patients
    Corticosteroid1.1%
    Prednisone100%
    Part D<11 patients

    + 1 more class in this area

  • Blood & clotting

    4.7%
    Factor Xa inhibitor3.7%
    Eliquis100%
    Part D13 patients
    P2Y12 inhibitor1%
    Clopidogrel100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”